Click for best price
Systemic Cidiasis Market Size, Share 2024
Systemic candidiasis includes a spectrum of yeast infections caused by different species (types) of Candida. It is a serious infection that can affect the blood, heart, brain, eyes, bones, or other parts of the body.
This report aims to provide a comprehensive presentation of the global market for Systemic Candidiasis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Systemic Candidiasis. This report contains market size and forecasts of Systemic Candidiasis in global, including the following market information:
Global Systemic Candidiasis Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
The global Systemic Candidiasis market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Systemic Oral Azoles Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Systemic Candidiasis include Novartis Ag, Sanofi-Aventis, Pfizer, Inc., Merck And Co., Inc., Enzon Pharmaceuticals Inc., Bayer Ag, Astellas Pharma, Inc., Glaxosmithkline Plc and Abbott, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Systemic Candidiasis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Systemic Candidiasis Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Systemic Candidiasis Market Segment Percentages, by Type, 2023 (%)
Systemic Oral Azoles
Voriconazole
Liposomal Amphotericin B
Topical Antifungal Agents
Others
Global Systemic Candidiasis Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Systemic Candidiasis Market Segment Percentages, by Application, 2023 (%)
Hospital
Clinic
Others
Global Systemic Candidiasis Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Systemic Candidiasis Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Systemic Candidiasis revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Systemic Candidiasis revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis Ag
Sanofi-Aventis
Pfizer, Inc.
Merck And Co., Inc.
Enzon Pharmaceuticals Inc.
Bayer Ag
Astellas Pharma, Inc.
Glaxosmithkline Plc
Abbott
Cipla
Outline of Major Chapters:
Chapter 1: Introduces the definition of Systemic Candidiasis, market overview.
Chapter 2: Global Systemic Candidiasis market size in revenue.
Chapter 3: Detailed analysis of Systemic Candidiasis company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Systemic Candidiasis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Systemic Candidiasis Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Systemic Candidiasis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Systemic Candidiasis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Systemic Candidiasis Overall Market Size
2.1 Global Systemic Candidiasis Market Size: 2023 VS 2030
2.2 Global Systemic Candidiasis Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Systemic Candidiasis Players in Global Market
3.2 Top Global Systemic Candidiasis Companies Ranked by Revenue
3.3 Global Systemic Candidiasis Revenue by Companies
3.4 Top 3 and Top 5 Systemic Candidiasis Companies in Global Market, by Revenue in 2023
3.5 Global Companies Systemic Candidiasis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Systemic Candidiasis Players in Global Market
3.6.1 List of Global Tier 1 Systemic Candidiasis Companies
3.6.2 List of Global Tier 2 and Tier 3 Systemic Candidiasis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Systemic Candidiasis Market Size Markets, 2023 & 2030
4.1.2 Systemic Oral Azoles
4.1.3 Voriconazole
4.1.4 Liposomal Amphotericin B
4.1.5 Topical Antifungal Agents
4.1.6 Others
4.2 By Type - Global Systemic Candidiasis Revenue & Forecasts
4.2.1 By Type - Global Systemic Candidiasis Revenue, 2019-2024
4.2.2 By Type - Global Systemic Candidiasis Revenue, 2025-2030
4.2.3 By Type - Global Systemic Candidiasis Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Systemic Candidiasis Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Systemic Candidiasis Revenue & Forecasts
5.2.1 By Application - Global Systemic Candidiasis Revenue, 2019-2024
5.2.2 By Application - Global Systemic Candidiasis Revenue, 2025-2030
5.2.3 By Application - Global Systemic Candidiasis Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Systemic Candidiasis Market Size, 2023 & 2030
6.2 By Region - Global Systemic Candidiasis Revenue & Forecasts
6.2.1 By Region - Global Systemic Candidiasis Revenue, 2019-2024
6.2.2 By Region - Global Systemic Candidiasis Revenue, 2025-2030
6.2.3 By Region - Global Systemic Candidiasis Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Systemic Candidiasis Revenue, 2019-2030
6.3.2 US Systemic Candidiasis Market Size, 2019-2030
6.3.3 Canada Systemic Candidiasis Market Size, 2019-2030
6.3.4 Mexico Systemic Candidiasis Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Systemic Candidiasis Revenue, 2019-2030
6.4.2 Germany Systemic Candidiasis Market Size, 2019-2030
6.4.3 France Systemic Candidiasis Market Size, 2019-2030
6.4.4 U.K. Systemic Candidiasis Market Size, 2019-2030
6.4.5 Italy Systemic Candidiasis Market Size, 2019-2030
6.4.6 Russia Systemic Candidiasis Market Size, 2019-2030
6.4.7 Nordic Countries Systemic Candidiasis Market Size, 2019-2030
6.4.8 Benelux Systemic Candidiasis Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Systemic Candidiasis Revenue, 2019-2030
6.5.2 China Systemic Candidiasis Market Size, 2019-2030
6.5.3 Japan Systemic Candidiasis Market Size, 2019-2030
6.5.4 South Korea Systemic Candidiasis Market Size, 2019-2030
6.5.5 Southeast Asia Systemic Candidiasis Market Size, 2019-2030
6.5.6 India Systemic Candidiasis Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Systemic Candidiasis Revenue, 2019-2030
6.6.2 Brazil Systemic Candidiasis Market Size, 2019-2030
6.6.3 Argentina Systemic Candidiasis Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Systemic Candidiasis Revenue, 2019-2030
6.7.2 Turkey Systemic Candidiasis Market Size, 2019-2030
6.7.3 Israel Systemic Candidiasis Market Size, 2019-2030
6.7.4 Saudi Arabia Systemic Candidiasis Market Size, 2019-2030
6.7.5 UAE Systemic Candidiasis Market Size, 2019-2030
7 Systemic Candidiasis Companies Profiles
7.1 Novartis Ag
7.1.1 Novartis Ag Company Summary
7.1.2 Novartis Ag Business Overview
7.1.3 Novartis Ag Systemic Candidiasis Major Product Offerings
7.1.4 Novartis Ag Systemic Candidiasis Revenue in Global Market (2019-2024)
7.1.5 Novartis Ag Key News & Latest Developments
7.2 Sanofi-Aventis
7.2.1 Sanofi-Aventis Company Summary
7.2.2 Sanofi-Aventis Business Overview
7.2.3 Sanofi-Aventis Systemic Candidiasis Major Product Offerings
7.2.4 Sanofi-Aventis Systemic Candidiasis Revenue in Global Market (2019-2024)
7.2.5 Sanofi-Aventis Key News & Latest Developments
7.3 Pfizer, Inc.
7.3.1 Pfizer, Inc. Company Summary
7.3.2 Pfizer, Inc. Business Overview
7.3.3 Pfizer, Inc. Systemic Candidiasis Major Product Offerings
7.3.4 Pfizer, Inc. Systemic Candidiasis Revenue in Global Market (2019-2024)
7.3.5 Pfizer, Inc. Key News & Latest Developments
7.4 Merck And Co., Inc.
7.4.1 Merck And Co., Inc. Company Summary
7.4.2 Merck And Co., Inc. Business Overview
7.4.3 Merck And Co., Inc. Systemic Candidiasis Major Product Offerings
7.4.4 Merck And Co., Inc. Systemic Candidiasis Revenue in Global Market (2019-2024)
7.4.5 Merck And Co., Inc. Key News & Latest Developments
7.5 Enzon Pharmaceuticals Inc.
7.5.1 Enzon Pharmaceuticals Inc. Company Summary
7.5.2 Enzon Pharmaceuticals Inc. Business Overview
7.5.3 Enzon Pharmaceuticals Inc. Systemic Candidiasis Major Product Offerings
7.5.4 Enzon Pharmaceuticals Inc. Systemic Candidiasis Revenue in Global Market (2019-2024)
7.5.5 Enzon Pharmaceuticals Inc. Key News & Latest Developments
7.6 Bayer Ag
7.6.1 Bayer Ag Company Summary
7.6.2 Bayer Ag Business Overview
7.6.3 Bayer Ag Systemic Candidiasis Major Product Offerings
7.6.4 Bayer Ag Systemic Candidiasis Revenue in Global Market (2019-2024)
7.6.5 Bayer Ag Key News & Latest Developments
7.7 Astellas Pharma, Inc.
7.7.1 Astellas Pharma, Inc. Company Summary
7.7.2 Astellas Pharma, Inc. Business Overview
7.7.3 Astellas Pharma, Inc. Systemic Candidiasis Major Product Offerings
7.7.4 Astellas Pharma, Inc. Systemic Candidiasis Revenue in Global Market (2019-2024)
7.7.5 Astellas Pharma, Inc. Key News & Latest Developments
7.8 Glaxosmithkline Plc
7.8.1 Glaxosmithkline Plc Company Summary
7.8.2 Glaxosmithkline Plc Business Overview
7.8.3 Glaxosmithkline Plc Systemic Candidiasis Major Product Offerings
7.8.4 Glaxosmithkline Plc Systemic Candidiasis Revenue in Global Market (2019-2024)
7.8.5 Glaxosmithkline Plc Key News & Latest Developments
7.9 Abbott
7.9.1 Abbott Company Summary
7.9.2 Abbott Business Overview
7.9.3 Abbott Systemic Candidiasis Major Product Offerings
7.9.4 Abbott Systemic Candidiasis Revenue in Global Market (2019-2024)
7.9.5 Abbott Key News & Latest Developments
7.10 Cipla
7.10.1 Cipla Company Summary
7.10.2 Cipla Business Overview
7.10.3 Cipla Systemic Candidiasis Major Product Offerings
7.10.4 Cipla Systemic Candidiasis Revenue in Global Market (2019-2024)
7.10.5 Cipla Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Systemic Candidiasis Market Opportunities & Trends in Global Market
Table 2. Systemic Candidiasis Market Drivers in Global Market
Table 3. Systemic Candidiasis Market Restraints in Global Market
Table 4. Key Players of Systemic Candidiasis in Global Market
Table 5. Top Systemic Candidiasis Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Systemic Candidiasis Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Systemic Candidiasis Revenue Share by Companies, 2019-2024
Table 8. Global Companies Systemic Candidiasis Product Type
Table 9. List of Global Tier 1 Systemic Candidiasis Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Systemic Candidiasis Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Systemic Candidiasis Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Systemic Candidiasis Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Systemic Candidiasis Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Systemic Candidiasis Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Systemic Candidiasis Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Systemic Candidiasis Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Systemic Candidiasis Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Systemic Candidiasis Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Systemic Candidiasis Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Systemic Candidiasis Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Systemic Candidiasis Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Systemic Candidiasis Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Systemic Candidiasis Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Systemic Candidiasis Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Systemic Candidiasis Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Systemic Candidiasis Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Systemic Candidiasis Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Systemic Candidiasis Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Systemic Candidiasis Revenue, (US$, Mn), 2025-2030
Table 30. Novartis Ag Company Summary
Table 31. Novartis Ag Systemic Candidiasis Product Offerings
Table 32. Novartis Ag Systemic Candidiasis Revenue (US$, Mn) & (2019-2024)
Table 33. Novartis Ag Key News & Latest Developments
Table 34. Sanofi-Aventis Company Summary
Table 35. Sanofi-Aventis Systemic Candidiasis Product Offerings
Table 36. Sanofi-Aventis Systemic Candidiasis Revenue (US$, Mn) & (2019-2024)
Table 37. Sanofi-Aventis Key News & Latest Developments
Table 38. Pfizer, Inc. Company Summary
Table 39. Pfizer, Inc. Systemic Candidiasis Product Offerings
Table 40. Pfizer, Inc. Systemic Candidiasis Revenue (US$, Mn) & (2019-2024)
Table 41. Pfizer, Inc. Key News & Latest Developments
Table 42. Merck And Co., Inc. Company Summary
Table 43. Merck And Co., Inc. Systemic Candidiasis Product Offerings
Table 44. Merck And Co., Inc. Systemic Candidiasis Revenue (US$, Mn) & (2019-2024)
Table 45. Merck And Co., Inc. Key News & Latest Developments
Table 46. Enzon Pharmaceuticals Inc. Company Summary
Table 47. Enzon Pharmaceuticals Inc. Systemic Candidiasis Product Offerings
Table 48. Enzon Pharmaceuticals Inc. Systemic Candidiasis Revenue (US$, Mn) & (2019-2024)
Table 49. Enzon Pharmaceuticals Inc. Key News & Latest Developments
Table 50. Bayer Ag Company Summary
Table 51. Bayer Ag Systemic Candidiasis Product Offerings
Table 52. Bayer Ag Systemic Candidiasis Revenue (US$, Mn) & (2019-2024)
Table 53. Bayer Ag Key News & Latest Developments
Table 54. Astellas Pharma, Inc. Company Summary
Table 55. Astellas Pharma, Inc. Systemic Candidiasis Product Offerings
Table 56. Astellas Pharma, Inc. Systemic Candidiasis Revenue (US$, Mn) & (2019-2024)
Table 57. Astellas Pharma, Inc. Key News & Latest Developments
Table 58. Glaxosmithkline Plc Company Summary
Table 59. Glaxosmithkline Plc Systemic Candidiasis Product Offerings
Table 60. Glaxosmithkline Plc Systemic Candidiasis Revenue (US$, Mn) & (2019-2024)
Table 61. Glaxosmithkline Plc Key News & Latest Developments
Table 62. Abbott Company Summary
Table 63. Abbott Systemic Candidiasis Product Offerings
Table 64. Abbott Systemic Candidiasis Revenue (US$, Mn) & (2019-2024)
Table 65. Abbott Key News & Latest Developments
Table 66. Cipla Company Summary
Table 67. Cipla Systemic Candidiasis Product Offerings
Table 68. Cipla Systemic Candidiasis Revenue (US$, Mn) & (2019-2024)
Table 69. Cipla Key News & Latest Developments
List of Figures
Figure 1. Systemic Candidiasis Segment by Type in 2023
Figure 2. Systemic Candidiasis Segment by Application in 2023
Figure 3. Global Systemic Candidiasis Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Systemic Candidiasis Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Systemic Candidiasis Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Systemic Candidiasis Revenue in 2023
Figure 8. By Type - Global Systemic Candidiasis Revenue Market Share, 2019-2030
Figure 9. By Application - Global Systemic Candidiasis Revenue Market Share, 2019-2030
Figure 10. By Type - Global Systemic Candidiasis Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Systemic Candidiasis Revenue Market Share, 2019-2030
Figure 12. By Application - Global Systemic Candidiasis Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Systemic Candidiasis Revenue Market Share, 2019-2030
Figure 14. By Region - Global Systemic Candidiasis Revenue Market Share, 2019-2030
Figure 15. By Country - North America Systemic Candidiasis Revenue Market Share, 2019-2030
Figure 16. US Systemic Candidiasis Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Systemic Candidiasis Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Systemic Candidiasis Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Systemic Candidiasis Revenue Market Share, 2019-2030
Figure 20. Germany Systemic Candidiasis Revenue, (US$, Mn), 2019-2030
Figure 21. France Systemic Candidiasis Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Systemic Candidiasis Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Systemic Candidiasis Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Systemic Candidiasis Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Systemic Candidiasis Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Systemic Candidiasis Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Systemic Candidiasis Revenue Market Share, 2019-2030
Figure 28. China Systemic Candidiasis Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Systemic Candidiasis Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Systemic Candidiasis Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Systemic Candidiasis Revenue, (US$, Mn), 2019-2030
Figure 32. India Systemic Candidiasis Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Systemic Candidiasis Revenue Market Share, 2019-2030
Figure 34. Brazil Systemic Candidiasis Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Systemic Candidiasis Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Systemic Candidiasis Revenue Market Share, 2019-2030
Figure 37. Turkey Systemic Candidiasis Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Systemic Candidiasis Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Systemic Candidiasis Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Systemic Candidiasis Revenue, (US$, Mn), 2019-2030
Figure 41. Novartis Ag Systemic Candidiasis Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Sanofi-Aventis Systemic Candidiasis Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Pfizer, Inc. Systemic Candidiasis Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Merck And Co., Inc. Systemic Candidiasis Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Enzon Pharmaceuticals Inc. Systemic Candidiasis Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Bayer Ag Systemic Candidiasis Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Astellas Pharma, Inc. Systemic Candidiasis Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Glaxosmithkline Plc Systemic Candidiasis Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Abbott Systemic Candidiasis Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Cipla Systemic Candidiasis Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
